Atlas Trials

Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients

Clinical trial NCT07526298 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07526298
Sponsor
IRCCS San Raffaele
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Neuromyelitis Optica Spectrum Disorders
Start date
2026-04-01
Primary completion
2027-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.